Mueller, K. L., Madden, J. M., Zoratti, G. L., Kuperwasser, C., List, K., & Boerner, J. L. (2012). Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met. BioMed Central.

Mueller, Kelly L., Julie M. Madden, Gina L. Zoratti, Charlotte Kuperwasser, Karin List, e Julie L. Boerner. Fibroblast-secreted Hepatocyte Growth Factor Mediates Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Triple-negative Breast Cancers Through Paracrine Activation of Met. BioMed Central, 2012.

Mueller, Kelly L., et al. Fibroblast-secreted Hepatocyte Growth Factor Mediates Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Triple-negative Breast Cancers Through Paracrine Activation of Met. BioMed Central, 2012.